Scholars@Duke

Risk of neutropenic complications in patients receiving systemic chemotherapy: Prospective risk model development.

Publication ,  Conference
Crawford, J; Dale, DC; Wolff, D; Agboola, O; Culakova, E; Lyman, GH
Published in: BLOOD
2003

Duke Scholars

Gary Herbert Lyman
Author Gary Herbert Lyman Medicine, Medical Oncology

Published In

BLOOD

ISSN

0006-4971

Publication Date

2003

Volume

102

Issue

11

Start / End Page

168B / 169B

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Crawford, J., Dale, D. C., Wolff, D., Agboola, O., Culakova, E., & Lyman, G. H. (2003). Risk of neutropenic complications in patients receiving systemic chemotherapy: Prospective risk model development. In BLOOD (Vol. 102, pp. 168B-169B).
Crawford, J., D. C. Dale, D. Wolff, O. Agboola, E. Culakova, and G. H. Lyman. “Risk of neutropenic complications in patients receiving systemic chemotherapy: Prospective risk model development.” In BLOOD, 102:168B-169B, 2003.
Crawford J, Dale DC, Wolff D, Agboola O, Culakova E, Lyman GH. Risk of neutropenic complications in patients receiving systemic chemotherapy: Prospective risk model development. In: BLOOD. 2003. p. 168B-169B.
Crawford J, Dale DC, Wolff D, Agboola O, Culakova E, Lyman GH. Risk of neutropenic complications in patients receiving systemic chemotherapy: Prospective risk model development. BLOOD. 2003. p. 168B-169B.

Published In

BLOOD

ISSN

0006-4971

Publication Date

2003

Volume

102

Issue

11

Start / End Page

168B / 169B

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology